Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)

Background. Malignant neoplasms of the vulva account for about 4 % of all gynecological cancer neoplasms. Every year in Russia more than 2000 new cases of vulvar cancer are registered, in the North-Western Federal Region of Russia (NWFRR)1 – more than 200 (2022). The incidence rate for Russia as a w...

Full description

Saved in:
Bibliographic Details
Main Authors: V. M. Merabishvili, I. V. Berlev, A. F. Urmancheeva, E. V. Bakhidze, E. A. Ulrikh
Format: Article
Language:Russian
Published: ABV-press 2025-03-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1315
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849241558209003520
author V. M. Merabishvili
I. V. Berlev
A. F. Urmancheeva
E. V. Bakhidze
E. A. Ulrikh
author_facet V. M. Merabishvili
I. V. Berlev
A. F. Urmancheeva
E. V. Bakhidze
E. A. Ulrikh
author_sort V. M. Merabishvili
collection DOAJ
description Background. Malignant neoplasms of the vulva account for about 4 % of all gynecological cancer neoplasms. Every year in Russia more than 2000 new cases of vulvar cancer are registered, in the North-Western Federal Region of Russia (NWFRR)1 – more than 200 (2022). The incidence rate for Russia as a whole is within 2.5 cases per 100,000 female population (in the NWFRR – about 3,00/0000). Standardized incidence rates for Russia and the NWFRR are within 1.1 and 1.20/0000. Before the age of 30, vulvar cancer practically does not occur; the maximum number (200–300) of cases is registered mainly among women over 60 years of age. There is no information on the mortality rate of the female population for this cancer localization in Russia, as well as calculations of such analytical indicators as mortality and patient survival, information about which can only be obtained on the basis of databases of individual population cancer registries.Aim. To study the prevalence of vulvar cancer based on the newly created population cancer registries database of the NWFRR, to consider the detailed structure of this tumor localization taking into account the fourth digit of the International Classification of Diseases-10, the histological structure of tumors, and the calculation of one-year and five-year patient survival.Materials and methods. The research material is data from the International Agency for Research on Cancer, reference books P.A. Herzen National Medical Research Center of Oncology and National Medical Research Oncology Center, databases of population cancer registries of Saint Petersburg and the NWFRR. Data processing was carried out using licensed programs MS Excel 2013–2016 and Statistica 6.1. To calculate survival, a modified Eurocare program was used, as well as mathematical, bibliographic and statistical methods.Results and conclusion. The first population-based study of the prevalence and effectiveness of anti-cancer measures based on the population cancer registries database, conducted in Russia, showed an increase in morbidity among the female population of malignant tumors of the vulva, decreased mortality of patients at each year of observation. The one-year relative survival rate of patients with vulvar cancer reached 72.0 %, five-year – 41.8 %. One-year survival rate by stage of the disease: I stage – 91.6 %, II stage – 79.7 %, III stage – 53.1 %, IV stage – 29.0 %. Five-year survival rate by stage of the disease: I stage – 68.2 %, II stage – 46.7 %, III stage – 18.6 %, IV stage – 5.6 %.
format Article
id doaj-art-4e7e70e3168e466f84bb61db349ccf53
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2025-03-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-4e7e70e3168e466f84bb61db349ccf532025-08-20T04:00:08ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272025-03-01204334310.17650/1994-4098-2024-20-4-33-43875Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)V. M. Merabishvili0I. V. Berlev1A. F. Urmancheeva2E. V. Bakhidze3E. A. Ulrikh4N.N. Petrov National Medical Research Oncology Center, Ministry of Health of RussiaN.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of RussiaN.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of RussiaN.N. Petrov National Medical Research Oncology Center, Ministry of Health of RussiaN.N. Petrov National Medical Research Oncology Center, Ministry of Health of Russia; I.I. Mechnikov North-Western State Medical University, Ministry of Health of Russia; V.A. Almazov National Medical Research Center, Ministry of Health of RussiaBackground. Malignant neoplasms of the vulva account for about 4 % of all gynecological cancer neoplasms. Every year in Russia more than 2000 new cases of vulvar cancer are registered, in the North-Western Federal Region of Russia (NWFRR)1 – more than 200 (2022). The incidence rate for Russia as a whole is within 2.5 cases per 100,000 female population (in the NWFRR – about 3,00/0000). Standardized incidence rates for Russia and the NWFRR are within 1.1 and 1.20/0000. Before the age of 30, vulvar cancer practically does not occur; the maximum number (200–300) of cases is registered mainly among women over 60 years of age. There is no information on the mortality rate of the female population for this cancer localization in Russia, as well as calculations of such analytical indicators as mortality and patient survival, information about which can only be obtained on the basis of databases of individual population cancer registries.Aim. To study the prevalence of vulvar cancer based on the newly created population cancer registries database of the NWFRR, to consider the detailed structure of this tumor localization taking into account the fourth digit of the International Classification of Diseases-10, the histological structure of tumors, and the calculation of one-year and five-year patient survival.Materials and methods. The research material is data from the International Agency for Research on Cancer, reference books P.A. Herzen National Medical Research Center of Oncology and National Medical Research Oncology Center, databases of population cancer registries of Saint Petersburg and the NWFRR. Data processing was carried out using licensed programs MS Excel 2013–2016 and Statistica 6.1. To calculate survival, a modified Eurocare program was used, as well as mathematical, bibliographic and statistical methods.Results and conclusion. The first population-based study of the prevalence and effectiveness of anti-cancer measures based on the population cancer registries database, conducted in Russia, showed an increase in morbidity among the female population of malignant tumors of the vulva, decreased mortality of patients at each year of observation. The one-year relative survival rate of patients with vulvar cancer reached 72.0 %, five-year – 41.8 %. One-year survival rate by stage of the disease: I stage – 91.6 %, II stage – 79.7 %, III stage – 53.1 %, IV stage – 29.0 %. Five-year survival rate by stage of the disease: I stage – 68.2 %, II stage – 46.7 %, III stage – 18.6 %, IV stage – 5.6 %.https://ojrs.abvpress.ru/ojrs/article/view/1315vulvar cancerrussianorth-western federal region of russiaincidencestagehistological structureannual mortality and survival ratepopulation cancer registries database
spellingShingle V. M. Merabishvili
I. V. Berlev
A. F. Urmancheeva
E. V. Bakhidze
E. A. Ulrikh
Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
Опухоли женской репродуктивной системы
vulvar cancer
russia
north-western federal region of russia
incidence
stage
histological structure
annual mortality and survival rate
population cancer registries database
title Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
title_full Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
title_fullStr Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
title_full_unstemmed Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
title_short Malignant neoplasms of the vulva: epidemiology and survival of patients in Russia (clinical-population study)
title_sort malignant neoplasms of the vulva epidemiology and survival of patients in russia clinical population study
topic vulvar cancer
russia
north-western federal region of russia
incidence
stage
histological structure
annual mortality and survival rate
population cancer registries database
url https://ojrs.abvpress.ru/ojrs/article/view/1315
work_keys_str_mv AT vmmerabishvili malignantneoplasmsofthevulvaepidemiologyandsurvivalofpatientsinrussiaclinicalpopulationstudy
AT ivberlev malignantneoplasmsofthevulvaepidemiologyandsurvivalofpatientsinrussiaclinicalpopulationstudy
AT afurmancheeva malignantneoplasmsofthevulvaepidemiologyandsurvivalofpatientsinrussiaclinicalpopulationstudy
AT evbakhidze malignantneoplasmsofthevulvaepidemiologyandsurvivalofpatientsinrussiaclinicalpopulationstudy
AT eaulrikh malignantneoplasmsofthevulvaepidemiologyandsurvivalofpatientsinrussiaclinicalpopulationstudy